Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongpan Zhang

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Stem Cell Reviews and Reports|July 29, 2025
The Integration of Olink Proteomics with Transcriptomics Elucidates that TNF-α Induces Senescence and Apoptosis in Transplanted Mesenchymal Stem CellsYuchuan Zhou, Jianbo Xiao, Shu Peng, et al.
Scientific Reports|October 3, 2024
Comprehensive analysis reveals that P4HA3 is a prognostic and diagnostic gastric cancer biomarker that can predict immunotherapy efficacyYuanhang Yu, Kexin Luo, Meihan Liu, et al.
Frontiers in Genetics|December 19, 2024
Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinomaHaiyang Zhao, Kexin Luo, Meihan Liu, et al.
Frontiers in Genetics|November 7, 2024
Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinomaHaiyang Zhao, Kexin Luo, Meihan Liu, et al.
Medical Oncology (Northwood, London, England)|February 6, 2026
CD168 in lung adenocarcinoma: prognostic relevance, immune feature associations, and MAPK/ERK pathway enrichmentMeihan Liu, Kexin Luo, Yaoshu Song, et al.
Frontiers in Molecular Biosciences|April 19, 2021
An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell CarcinomaHongpan Zhang, Qi Shi, Zhihao Yang, et al.
Technology in Cancer Research & Treatment|November 12, 2020
<i>RAI14</i> Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric CancerYu Xiao, Hongpan Zhang, Guobo Du, et al.
Oncology Reports|March 2, 2021
Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinomaZhihao Yang, Yi Hui, Hao Peng, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 26, 2020
Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles AnalysisMenglu Li, Kaige Wang, Yanhua Pang, et al.
Journal of Cancer Research and Clinical Oncology|March 17, 2022
Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosisHongpan Zhang, Meihan Liu, Guobo Du, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Stem Cell Reviews and Reports|July 29, 2025
The Integration of Olink Proteomics with Transcriptomics Elucidates that TNF-α Induces Senescence and Apoptosis in Transplanted Mesenchymal Stem CellsYuchuan Zhou, Jianbo Xiao, Shu Peng, et al.
Scientific Reports|October 3, 2024
Comprehensive analysis reveals that P4HA3 is a prognostic and diagnostic gastric cancer biomarker that can predict immunotherapy efficacyYuanhang Yu, Kexin Luo, Meihan Liu, et al.
Frontiers in Genetics|December 19, 2024
Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinomaHaiyang Zhao, Kexin Luo, Meihan Liu, et al.
Frontiers in Genetics|November 7, 2024
Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinomaHaiyang Zhao, Kexin Luo, Meihan Liu, et al.
Medical Oncology (Northwood, London, England)|February 6, 2026
CD168 in lung adenocarcinoma: prognostic relevance, immune feature associations, and MAPK/ERK pathway enrichmentMeihan Liu, Kexin Luo, Yaoshu Song, et al.
Frontiers in Molecular Biosciences|April 19, 2021
An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell CarcinomaHongpan Zhang, Qi Shi, Zhihao Yang, et al.
Technology in Cancer Research & Treatment|November 12, 2020
<i>RAI14</i> Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric CancerYu Xiao, Hongpan Zhang, Guobo Du, et al.
Oncology Reports|March 2, 2021
Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinomaZhihao Yang, Yi Hui, Hao Peng, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 26, 2020
Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles AnalysisMenglu Li, Kaige Wang, Yanhua Pang, et al.
Journal of Cancer Research and Clinical Oncology|March 17, 2022
Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosisHongpan Zhang, Meihan Liu, Guobo Du, et al.
Pageof 4